BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang P, Jin SY. Meta-analysis of the efficacy and safety of daratumumab in the treatment of multiple myeloma. World J Clin Cases 2023; 11(29): 7091-7100 [PMID: 37946760 DOI: 10.12998/wjcc.v11.i29.7091]
URL: https://www.wjgnet.com/2307-8960/full/v11/i29/7091.htm
Number Citing Articles
1
Yanchen Nie, Zongxin Zhang, Xiaohuan Tang. Prognostic and clinicopathological value of prognostic nutritional index in patients with multiple myeloma: a meta-analysisFrontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1545096
2
Massimo Martino, Mercedes Gori, Gaetana Porto, Giorgia Policastro, Martina Pitea, Annalisa Sgarlata, Ilaria Maria Delfino, Francesca Cogliandro, Anna Scopelliti, Giovanna Utano, Maria Pellicano, Aurora Idato, Iolanda Donatella Vincelli, Violetta Marafioti, Maria Caterina Micò, Giuseppe Lazzaro, Barbara Loteta, Caterina Alati, Giovanni Leanza, Graziella D’Arrigo, Giovanni Luigi Tripepi, Annalisa Pitino. First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center StudyCancers 2024; 16(19): 3307 doi: 10.3390/cancers16193307